Stock Events

Stock Events

Direxion Daily S&P Biotech Bear 3X Shares

$7.33

38

+$0.07+0.96% Friday 20:00

Statistics

Day High

7.53

Day Low

7.19

52W High

28.65

52W Low

5.55

Volume

13,042,855

Avg. Volume

12,812,219

Mkt Cap

102M

P/E Ratio

0

Dividend Yield

5.89%

Dividend

0.43

Upcoming

Dividends

5.89%Dividend Yield

10Y Growth

N/A

5Y Growth

14.82%

3Y Growth

N/A

1Y Growth

-27.37%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LABD. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares, the bullish counterpart to LABD, offering 3x leveraged exposure to the same index but for those betting on the index's rise.

ProShares UltraShort Nasdaq Biotechnology -2x Shares

ProShares UltraShort Nasdaq Biotechnology, offers 2x daily short leverage to the NASDAQ Biotechnology Index, competing directly with LABD's inverse biotech focus.

VanEck Vectors Biotech ETF, provides exposure to the biotech industry, competing with LABD by targeting the same sector without leverage.

iShares Biotechnology

iShares Biotechnology ETF, tracks the same biotech sector as LABD, offering an alternative for investors looking to invest in biotech without leverage.

SPDR S&P Biotech ETF, competes by offering exposure to the biotech sector, similar to LABD but without the leveraged inverse strategy.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF, targets the biotech and healthcare sectors, providing an alternative investment in the same industry as LABD.

ProShares Ultra Nasdaq Biotechnology 2X Shares

ProShares Ultra Nasdaq Biotechnology, offers 2x daily leverage to the NASDAQ Biotechnology Index, competing with LABD by targeting the same sector with a bullish perspective.

Virtus LifeSci Biotech Products

Virtus LifeSci Biotech Products ETF, competes by investing in biotech product companies, offering a different angle on the same sector as LABD.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund, competes by providing exposure to biotech firms, similar to LABD's focus but without the leveraged inverse strategy.

About

Miscellaneous

Investment Trusts/Mutual Funds

The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Show more...

CEO

Country

US

ISIN

US25460G7161

Listings